HELX

Franklin Templeton$35.63+0.00 (+0.00%)
AUM $23.2MER 0.50%NAV $35.73Holdings 63

Price Chart

Key Statistics

Previous Close

$34.97

Day Range

$35.63$35.68

52-Week Range

$27.02$38.10

Avg Volume

204

Dividend Yield

0.43%

Expense Ratio

0.50%

AUM

$23.2M

Shares Outstanding

498.0K

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare96.50%
Basic Materials2.65%
Technology0.85%

Country Allocation

CountryWeight %
United States84.24%
United Kingdom3.27%
South Korea3.05%
Germany2.65%
Other2.22%
Netherlands2.17%
Switzerland1.40%
Ireland0.86%
Singapore0.13%

Fund Information

Category
Healthcare
Inception Date
Feb 25, 2020
Exchange
BATS
Description
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$38.75B
VHTVanguard Health Care ETF$18.50B
COWZPacer US Cash Cows 100 ETF$18.42B
RWLInvesco S&P 500 Revenue ETF$9.16B
XBIState Street SPDR S&P Biotech ETF$8.07B

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund issued by Franklin Templeton that launched on Feb 25, 2020. It currently manages $23.2M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 63 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 45.2% of the fund

RankSymbolNameWeight %SharesMarket Value
1GHGUARDANT HEALTH INC8.86%15,718$2.0M
2NTRANATERA INC6.70%7,131$1.5M
3KRYSKRYSTAL BIOTECH INC5.91%4,418$1.3M
4UTHRUNITED THERAPEUTICS CORP4.09%1,680$923K
5LGNDLIGAND PHARMACEUTICALS3.94%3,794$889K
6BBIOBRIDGEBIO PHARMA INC3.54%12,192$798K
7ADPTADAPTIVE BIOTECHNOLOGIES3.42%48,245$771K
8LLYELI LILLY & CO3.06%639$689K
9AZN.LASTRAZENECA PLC2.89%3,695$651K
10INSMINSMED INC2.73%5,932$616K
11VRTXVERTEX PHARMACEUTICALS IN2.73%1,435$615K
12207940.KSSAMSUNG BIOLOGICS CO LTD2.61%652$588K
13CTVACORTEVA INC2.38%6,904$537K
14TWSTTWIST BIOSCIENCE CORP2.30%7,184$520K
15CASH2.28%514,080$514K
Page 1 of 2

Detailed Returns

PeriodReturnETF
1D
+0.00%
1W
-0.11%
1M
+5.64%
3M
+9.96%
6M
-3.45%
YTD
-2.12%
1Y
+29.59%
3Y
+14.69%
5Y
-24.04%

Moving Averages

20-Day MA

$34.46

Above 20-Day MA
50-Day MA

$34.01

Above 50-Day MA
200-Day MA

$33.88

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$38.10

Current Price

$35.63

52-Week Low

$27.02

$27.02$38.10

Current Yield

0.43%

Annual Dividend

$0.3132

Frequency

1x/year

Last Ex-Date

Dec 30, 2025

Dividend History

Ex-DateAmountPay Date
Dec 30, 2025$0.1433Jan 8, 2026
Dec 30, 2021$0.0039Jan 7, 2022
Dec 13, 2021$0.1141Dec 21, 2021
Dec 14, 2020$0.0518Dec 23, 2020

Dividend Payments Over Time

Category Comparison

MetricHELXHealthcare(174 ETFs)Genomics(11 ETFs)
Fund Info
Expense Ratio0.50%0.60%0.61%
AUM$23.2M$875.8M$222.1M
Dividend Yield0.43%3.42%39.63%
Avg Volume204270.2K317.4K
Holdings638951
Performance
1-Month Return+5.26%+2.02%+2.87%
6-Month Return-2.65%+3.84%+3.71%
YTD Return-1.66%+3.23%+5.83%
1-Year Return+29.70%+23.91%+18.76%

Compare with Another ETF

Search for an ETF to compare with HELX:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.